Biogen Reiterates Byooviz Will Not Be Meaningful In 2022

Launches Outside Of The US Scheduled For Early 2023

 
• By Dean Rudge
  
Eye
Coherus is set to rival Biogen's Byooviz launch • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Archive

More from Generics Bulletin